Auria has a sensitivity of 92% which means out of 100 women with breast cancer, Auria would classify 92 of those women as clinically significant (or above the diagnostic threshold); the remaining 8 are identified as negative.

Auria has a specificity of 58%, which means out of 100 normal women, Auria would classify 58 of them as negative.

We have preferentially selected our algorithm to have a higher sensitivity in order to reduce the number of missed cancers (i.e. false negatives). As with all lab-developed tests, continued use of our assay will allow for optimization of the diagnostic parameters.

Yes, some FSA’s and HSA’s allow for purchase of at home laboratory tests, but please check with your benefits department to be sure. To receive your "super bill" or EOB for HSA/FSA reimbursement, please contact customer service. At this time, the cost of Auria is not covered by insurance.

Your test results will provide you a score and classification of low, medium, or high. A medium or high classification does not mean you have breast cancer, but rather the score produced from your sample could be elevated due to a breast abnormality.  Your classification will give you a recommended timeframe to get a screening mammogram or other imaging.

During the consultation, the BHS will review your results and the information you provided in your breast health survey and will guide you through potential next steps. You will understand the impact of modifiable risk factors on your breast health, and you will have an open session time for you to ask any lingering questions you may have. In addition, you can expect a comprehensive report outlining the discussion and next steps afterward.

This is your time with our specialist, and you can discuss anything you would like concerning breast health. Note down any questions you may have for your BHS. Visit our Glossary!